{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:, Debie, Yana, Van Audenaerde Jonas R. M., Vandamme Timon, Croes Lieselot, Teuwen Laure-Anne, Verbruggen Lise, Vanhoutte Greetje, Marcq Elly, Verheggen Lisa, Le Blon Debbie, et al. , Clinical Cancer Research, Mar-11-2022, Volume 29, Issue 3, (2022)\par \par }